DANIEL HAMSTRA to Antineoplastic Agents
This is a "connection" page, showing publications DANIEL HAMSTRA has written about Antineoplastic Agents.
Connection Strength
0.976
-
MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner. Neoplasia. 2016 04; 18(4):213-22.
Score: 0.274
-
Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol. 2007 Sep 10; 25(26):4104-9.
Score: 0.151
-
The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies. Mol Ther. 2004 Nov; 10(5):916-28.
Score: 0.124
-
Expression of endogenously activated secreted or cell surface carboxypeptidase A sensitizes tumor cells to methotrexate-alpha-peptide prodrugs. Cancer Res. 2000 Feb 01; 60(3):657-65.
Score: 0.089
-
Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer. Head Neck. 2018 07; 40(7):1375-1388.
Score: 0.078
-
High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir =0.2 to Select Men for Short-term Hormonal Therapy. Am J Clin Oncol. 2017 Aug; 40(4):348-352.
Score: 0.075
-
Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol. 2016 Jan; 69(1):50-7.
Score: 0.064
-
Outcomes of multidisciplinary management in pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e481-8.
Score: 0.048
-
Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculature. Clin Cancer Res. 2009 Jan 15; 15(2):589-96.
Score: 0.042
-
High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer. Prostate Cancer Prostatic Dis. 2015 Sep; 18(3):229-36.
Score: 0.016
-
Concurrent whole brain radiotherapy and bortezomib for brain metastasis. Radiat Oncol. 2013 Aug 21; 8:204.
Score: 0.014